Mallinckrodt plc

  • TickerMNK
  • ISINIE00BBGT3753
  • ExchangeNew York Stock Exchange
  • SectorPharmaceuticals & Biotechnology
  • CountryIreland

ValuEngine Rating and Forecast Report for MNK

ValuEngine Rating and Forecast Report for MNK

ValuEngine Rating and Forecast Report for MNK

ValuEngine Rating and Forecast Report for MNK

ValuEngine Rating and Forecast Report for MNK

ValuEngine Rating and Forecast Report for MNK

ValuEngine Rating and Forecast Report for MNK

ValuEngine Rating and Forecast Report for MNK

ValuEngine Rating and Forecast Report for MNK

ValuEngine Rating and Forecast Report for MNK

1 director bought

A director at Mallinckrodt Plc bought 5,400 shares at 8.960USD and the significance rating of the trade was 51/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The names of boa...

Feasibility Study Results in December to be a Catalyst for this Junior

Feasibility Study Results in December to be a Catalyst for this Junior

Michael Waterhouse

Morningstar | Dropping Coverage of Mallinckrodt

We are dropping coverage of Mallinckrodt. We provide broad coverage of more than 1,500 companies globally and periodically adjust our coverage according to investor interest and staffing.

Michael Waterhouse

Dropping Coverage of Mallinckrodt

We are dropping coverage of Mallinckrodt. We provide broad coverage of more than 1,500 companies globally and periodically adjust our coverage according to investor interest and staffing. ...